Discussion: Mutant HIV-1 (
P90A or
G89V) infection of PBMCs or CD4+ T cells was 10-20-fold weaker than that of wild-type HIV-1.
Discussion: Mutations in the CypA-binding loop of the
capsid, such as
P90A and
G89V, cause an infectivity defect similar to that caused by CsA treatment during wild-type HIV-1 infection of Jurkat and CD4+ T cells; however, infection of HIV-1 viruses bearing the
capsid change
A92E or
G94D results in an infection that is insensitive to CsA treatment in Jurkat cells.